The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa.
about
Low primary and secondary HIV drug-resistance after 12 months of antiretroviral therapy in human immune-deficiency virus type 1 (HIV-1)-infected individuals from Kigali, RwandaCost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settingsHIV-1 drug resistance and resistance testing.Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa.Modeling the cost-effectiveness of HIV treatment: how to buy the most 'health' when resources are limited.Cost-effectiveness of genotype testing for primary resistance in BrazilImplementing antiretroviral resistance testing in a primary health care HIV treatment programme in rural KwaZulu-Natal, South Africa: early experiences, achievements and challenges.Emerging antiretroviral drug resistance in sub-Saharan Africa: novel affordable technologies are needed to provide resistance testing for individual and public health benefits.Should viral load thresholds be lowered?: Revisiting the WHO definition for virologic failure in patients on antiretroviral therapy in resource-limited settingsIncreasing rate of TAMs and etravirine resistance in HIV-1-infected adults between 12 and 24 months of treatment: the VOLTART cohort study in Côte d'Ivoire, West Africa.HIV-positive-to-HIV-positive kidney transplantation--results at 3 to 5 years.Implementing HIV-1 genotypic resistance testing in antiretroviral therapy programs in Africa: needs, opportunities, and challenges.The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates.Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.Random lopinavir concentrations predict resistance on lopinavir-based antiretroviral therapy.Next-Generation Human Immunodeficiency Virus Sequencing for Patient Management and Drug Resistance Surveillance.HIV-positive-to-HIV-positive kidney transplantation.Key Factors Influencing the Emergence of Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income Countries.Observed HIV drug resistance associated mutations amongst naïve immunocompetent children in Yaoundé, Cameroon.
P2860
Q28535266-344E9FB0-11E5-4E38-93A3-C4CBE4451CC2Q28543578-8B02C86C-4791-49D5-A947-902629853EB2Q30245693-66B98791-86BA-45F0-B82E-519F7CEBF84FQ33851741-884DDDEF-7ADA-4E38-9600-C8DB02369F3FQ33854542-7EA9DD82-A18D-42ED-81BD-FA30756A9CE6Q34964120-106B8DA4-EBDD-4911-BC15-503F6C0CDF29Q35114102-2828D3CF-B4F5-4E12-95E5-7C8B5846E5E7Q36669337-95A6919B-C1C2-4206-9C5C-261CDE8B229DQ37116750-E1099653-23C2-484B-87A5-F085B40B4E10Q37326870-CE76697D-56A9-4EE7-93AF-057AF91BDA9AQ37385691-9EB15802-7B03-4104-AEDC-BEBFA1276931Q37634044-BE8BDE20-2F33-40BA-B989-C2D49299653AQ38673571-BEA92AFC-E54F-4F39-9AF5-72421D7D383BQ38858252-029A1B12-22AC-44C9-8476-1CAD2DE7275EQ40636440-CD3130C2-2B52-41CC-989B-2BFB987CE19EQ41926464-23FAC0FD-4883-44AA-A5B4-99413CCE2F0BQ43187668-0CD9F3CB-205B-44EC-A846-DB173A0C19E2Q45323778-211A35B9-2234-4A4C-88DC-8AED97A073D8Q47138435-AB9D888A-2EEB-4AF5-B13A-B66156D42294
P2860
The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The clinical and economic impa ...... cted patients in South Africa.
@ast
The clinical and economic impa ...... cted patients in South Africa.
@en
type
label
The clinical and economic impa ...... cted patients in South Africa.
@ast
The clinical and economic impa ...... cted patients in South Africa.
@en
prefLabel
The clinical and economic impa ...... cted patients in South Africa.
@ast
The clinical and economic impa ...... cted patients in South Africa.
@en
P2093
P2860
P50
P356
P1476
The clinical and economic impa ...... cted patients in South Africa.
@en
P2093
Andrea L Ciaranello
Callie A Scott
Corina Rusu
Julie H Levison
Neil A Martinson
P2860
P304
P356
10.1093/CID/CIS887
P407
P577
2012-10-19T00:00:00Z